Matthieu Mahévas

6.0k total citations
38 papers, 810 citations indexed

About

Matthieu Mahévas is a scholar working on Hematology, Physiology and Immunology. According to data from OpenAlex, Matthieu Mahévas has authored 38 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 12 papers in Physiology and 8 papers in Immunology. Recurrent topics in Matthieu Mahévas's work include Platelet Disorders and Treatments (14 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Blood groups and transfusion (8 papers). Matthieu Mahévas is often cited by papers focused on Platelet Disorders and Treatments (14 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Blood groups and transfusion (8 papers). Matthieu Mahévas collaborates with scholars based in France, United States and Belgium. Matthieu Mahévas's co-authors include Claude–Agnès Reynaud, Jean–Claude Weill, Marc Michel, Étienne Crickx, Bertrand Godeau, Simon Le Gallou, Nicolas Cagnard, Dominique Valeyre, Lionel Galicier and David Boutboul and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Immunity.

In The Last Decade

Matthieu Mahévas

34 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthieu Mahévas France 14 259 246 223 171 143 38 810
Shogo Banno Japan 19 221 0.9× 204 0.8× 79 0.4× 270 1.6× 319 2.2× 91 1.1k
Sara Barmettler United States 13 470 1.8× 145 0.6× 60 0.3× 92 0.5× 128 0.9× 44 844
Piero Farruggia Italy 20 222 0.9× 207 0.8× 102 0.5× 71 0.4× 113 0.8× 62 889
Natacha Patey‐Mariaud de Serre France 14 296 1.1× 143 0.6× 105 0.5× 59 0.3× 106 0.7× 21 828
Étienne Crickx France 12 150 0.6× 163 0.7× 86 0.4× 48 0.3× 77 0.5× 25 421
Nicole Schlagwein Netherlands 12 753 2.9× 195 0.8× 68 0.3× 112 0.7× 83 0.6× 23 1.1k
Diana S. Beardsley United States 17 167 0.6× 877 3.6× 64 0.3× 148 0.9× 200 1.4× 30 1.3k
J.M. Durand France 15 153 0.6× 250 1.0× 33 0.1× 76 0.4× 158 1.1× 37 690
James Chung United States 21 966 3.7× 225 0.9× 76 0.3× 111 0.6× 67 0.5× 45 1.5k
A. E. G. Kr. v. d. Borne Netherlands 13 203 0.8× 215 0.9× 189 0.8× 254 1.5× 18 0.1× 17 603

Countries citing papers authored by Matthieu Mahévas

Since Specialization
Citations

This map shows the geographic impact of Matthieu Mahévas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Mahévas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Mahévas more than expected).

Fields of papers citing papers by Matthieu Mahévas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Mahévas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Mahévas. The network helps show where Matthieu Mahévas may publish in the future.

Co-authorship network of co-authors of Matthieu Mahévas

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Mahévas. A scholar is included among the top collaborators of Matthieu Mahévas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Mahévas. Matthieu Mahévas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moulis, Guillaume, Sylvain Audia, Louis Terriou, et al.. (2025). Efficacy and safety of dapsone in adult primary immune thrombocytopenia. Blood Advances. 9(8). 1976–1983.
2.
Tsykunova, Galina, Pål André Holme, Hoa Tran, et al.. (2025). Safety and efficacy of daratumumab in immune thrombocytopenia. Blood Advances. 10(1). 143–154.
3.
Mahévas, Matthieu, Jean‐François Viallard, Thibault Comont, et al.. (2023). Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents. Blood. 142(12). 1099–1101. 2 indexed citations
4.
Fauter, Maxime, G. Rossi, Marianne Latournerie, et al.. (2022). Hepatic sarcoidosis with symptomatic portal hypertension: A report of 12 cases with review of the literature. Frontiers in Medicine. 9. 995042–995042. 5 indexed citations
5.
Moulis, Guillaume, Étienne Crickx, Laure Thomas, et al.. (2022). De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring. Blood. 139(16). 2561–2565. 12 indexed citations
6.
Chappert, Pascal, François Huetz, Fabrice Chatonnet, et al.. (2022). Human anti-smallpox long-lived memory B cells are defined by dynamic interactions in the splenic niche and long-lasting germinal center imprinting. Immunity. 55(10). 1872–1890.e9. 16 indexed citations
7.
Bonaud, Amélie, Julie Nguyen, Valéria Bisio, et al.. (2021). Hematologic disorder–associated Cxcr4 gain-of-function mutation leads to uncontrolled extrafollicular immune response. Blood. 137(22). 3050–3063. 15 indexed citations
8.
Audia, Sylvain, Matthieu Mahévas, & Bernard Bonnotte. (2020). Thrombopénie immunologique : de la physiopathologie aux traitements. La Revue de Médecine Interne. 42(1). 16–24. 7 indexed citations
9.
Assan, Florence, F. Schlemmer, Jean‐Baptiste Assié, et al.. (2019). Atypical systemic sarcoid-like granulomatosis in two patients treated with BRAF and MEK inhibitors. European Journal of Dermatology. 29(5). 556–557. 6 indexed citations
10.
Bedet, Alexandre, Camille Petit-Hoang, Matthieu Mahévas, et al.. (2019). Acute Hippocampal Encephalopathy in Heavy Cannabis Users: About 2 Cases. The American Journal of Medicine. 133(7). e360–e364. 2 indexed citations
11.
Sokal, Aurélien, Thibault Comont, Nicolas Limal, et al.. (2019). Immune Thrombocytopenia in Very Elderly Patients: Particularities in Presentation and Management. Results from the Multicenter Prospective Carmen-France Registry. Blood. 134(Supplement_1). 1091–1091. 1 indexed citations
12.
Gallou, Simon Le, A. Robbins, Étienne Crickx, et al.. (2018). BAFF and CD4+ T cells are major survival factors for long-lived splenic plasma cells in a B-cell–depletion context. Blood. 131(14). 1545–1555. 57 indexed citations
13.
Schepers, Kinda, Sébastien Breurec, T. Messiaen, et al.. (2016). Severe Thrombocytopenia after Zika Virus Infection, Guadeloupe, 2016. Emerging infectious diseases. 23(4). 696–698. 28 indexed citations
14.
Georgin‐Lavialle, Sophie, K. Stankovic, Claude Bachmeyer, et al.. (2016). Les maladies autoinflammatoires inclassées existent-t- elles? A propos de 56 cas adultes. La Revue de Médecine Interne. 37. A68–A68.
15.
Mahévas, Matthieu, Marc Michel, Benoît Vingert, et al.. (2015). Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab. Journal of Autoimmunity. 62. 22–30. 50 indexed citations
16.
Schöfl, R, et al.. (2014). Il vaut mieux un bon coup d’œil que se creuser les méninges !. La Revue de Médecine Interne. 36(2). 135–139. 1 indexed citations
17.
Mahévas, Matthieu, Marc Michel, Jean–Claude Weill, & Claude–Agnès Reynaud. (2013). Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy. Frontiers in Immunology. 4. 494–494. 66 indexed citations
18.
Mahévas, Matthieu, Pauline Patin, François Huetz, et al.. (2012). B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. Journal of Clinical Investigation. 123(1). 432–442. 144 indexed citations
19.
Mahévas, Matthieu, François Xavier Lescure, Jean‐Jacques Boffa, et al.. (2009). Renal Sarcoidosis. Medicine. 88(2). 98–106. 126 indexed citations
20.
Mahévas, Matthieu, et al.. (2005). Article originalSpectre étiologique des hyperferritinémiesAetiological spectrum of hyperferritinemia. La Revue de Médecine Interne. 26(5). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shogo Banno Breakdown of academic impact, for papers by Sara Barmettler Breakdown of academic impact, for papers by Piero Farruggia Breakdown of academic impact, for papers by Natacha Patey‐Mariaud de Serre Breakdown of academic impact, for papers by Étienne Crickx Breakdown of academic impact, for papers by Nicole Schlagwein Breakdown of academic impact, for papers by Diana S. Beardsley Breakdown of academic impact, for papers by J.M. Durand Breakdown of academic impact, for papers by James Chung Breakdown of academic impact, for papers by A. E. G. Kr. v. d. Borne
Rankless by CCL
2026